Friday - November 7, 2025
A Combination Treatment May Help Cut Lifelong Ibrutinib for Chronic Lymphocytic Leukemia
November 06, 2025
PHILADELPHIA, Pennsylvania, Nov. 6 [Category: Medical] -- The American Association for Cancer Research posted the following news release:

* * *

A Combination Treatment May Help Cut Lifelong Ibrutinib for Chronic Lymphocytic Leukemia

*

Adding the investigational antibody ianalumab (VAY736) to ibrutinib (Imbruvica) allowed some patients with chronic lymphocytic leukemia (CLL) to discontinue daily therapy and potentially improve their quality of l . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products